Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20211017052786N4Phase 2Completed
Phase 2 trial of ropivacaine, sponsored by Qom University of Medical Sciences. Started Jun 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20211017052786N4.